A new meningitis vaccine known as Menactra The Centers for Disease Control and Prevention has recommended that wider use be made of a new meningitis vaccine known as Menactra and manufactured by Sanofi Pasteur. The following categories of young people are the ones the CDC is most interested in seeing vaccinated: all 11- and 12-year-olds; high school freshmen or children under 15, whichever comes earlier, and college freshmen living in dormitories.
about 3,000 people in the United States contract meningococcal disease
Each year about 3,000 people in the United States contract meningococcal disease. About 10% of these people die and another 15% may suffer serious permanent disabilities including loss of hearing, brain damage, or the loss of a limb.
Need Legal Help Regarding New Meningitis Vaccine?
The personal injury attorneys at Parker Waichman LLP offer free, no-obligation case evaluations. For more information, fill out our online contact form or call 1-800-YOURLAWYER (1-800-968-7529).
